Tntibiotic resistance is a growing problem and the main cause of this problem is misuse

Similar documents
Perspective on AnA Global timicrobial Resistance

Antimicrobial Resistance, yes we care! The European Joint Action

Canada s Activities in Combatting Antimicrobial Resistance. Presentation to the JPIAMR Management Board March 29, 2017

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

National Action Plan development support tools

EU strategy to fight against Antimicrobial Resistance

The Philippine Action Plan to Combat Antimicrobial Resistance: One Health Approach

Request for advice on the impact on public health and animal health of the use of antibiotics in animals

OIE PVS Pathway including Veterinary Education

EU Action Plan to combat the rising threats from Antimicrobial Resistance: State of play

Pan-Canadian Framework and Approach to Antimicrobial Resistance. Presentation to the TATFAR Policy Dialogue September 27, 2017

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

Council of the European Union Brussels, 13 June 2016 (OR. en)

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

WORLD ANTIBIOTIC AWARENESS WEEK

Strategy 2020 Final Report March 2017

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

World Organisation for Animal Health

Global Strategies to Address AMR Carmem Lúcia Pessoa-Silva, MD, PhD Antimicrobial Resistance Secretariat

Table Of Content. Dutch EU Presidency Conference on Antimicrobial Resistance... 2 Summary... 3 Work Package... 8

Comments from The Pew Charitable Trusts re: Consultation on a draft global action plan to address antimicrobial resistance September 1, 2014

Pan-Canadian Action Plan on Antimicrobial Resistance and Antimicrobial Use

The European AMR Challenge - strategic views from the human perspective -

International Activities In Antimicrobial Resistance

WHO perspective on antimicrobial resistance

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

Measures relating to antimicrobial resistance (AMR)

Hosted by Dr. Benedetta Allegranzi, WHO Patient Safety Agency A Webber Training Teleclass

EI SIG Strategic & 2002 Business Plan

European Medicines Agency role and experience on antimicrobial resistance

Antimicrobial Stewardship: The South African Perspective

Managing AMR at the Human-Animal Interface. OIE Contributions to the AMR Global Action Plan

Antimicrobial Resistance Initiative

Antibiotic resistance is one of the biggest threats to global health, food security, and development today.

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

Antimicrobial resistance

AMR situation in Europe: Strategy and vision

Stratégies et actions au niveau européen et international: populations humaines

Evaluation of EU strategy to combat AMR

OIE Resolution and activities related to the Global Action Plan. Regional Seminar for OIE National Focal Points for Veterinary Products 4 th Cycle

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

World Veterinary Association

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

2017 EU Action Plan against AMR state of play of implementation One-Health Network on AMR 26 October Brussels

The Veterinary Epidemiology and Risk Analysis Unit (VERAU)

OIE mission in the framework of One Health Focus on antimicrobial resistance (AMR)

Draft ESVAC Vision and Strategy

Antimicrobial Stewardship in Food Animals in Canada AMU/AMR WG Update Forum 2016

The European road map against antimicrobial resistance

OIE Role in International Trade

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

ANTIMICROBIAL RESISTANCE and causes of non-prudent use of antibiotics in human medicine in the EU

Antimicrobial Stewardship: Setting minimum expectations for optimizing antimicrobial use and addressing resistance

Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health

IFMSA Policy Proposal [Antimicrobial Resistance]

ANTIMICROBIAL RESISTANCE THE AUSTRALIAN CONTEXT. Professor Brendan Murphy Australian Government Chief Medical Officer

The Commission activities on AMR (focus on zoonotic issues)

First-year experiences in implementing Thailand s National Strategic Plan on AMR

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)

EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA

OIE Collaborating Centres Reports Activities

Overview of the OIE PVS Pathway

ONE HEALTH AND THE POWER OF PLATFORMS. One Health Models for Cross-Sectoral Coordination on Zoonotic Diseases

COPING WITH ANTIMICROBIAL RESISTANCE

NOTIFICATION TO THE PARTIES

The APUA Global Chapter Network:

Antimicrobial Stewardship: A Public Health Priority

Jaipur Declaration on Antimicrobial Resistance

COMMISSION OF THE EUROPEAN COMMUNITIES

OIE Reference Centres : General Overview

The ABCs of Antibiotic Stewardship

international news RECOMMENDATIONS

Speaking notes submitted by Dr. Duane Landals. on behalf of the Canadian Veterinary Medical Association (CVMA)

Dr Marc Sprenger Director Antimicrobial Resistance Secretariat Global action plan on antimicrobial resistance

EU Research on Antimicrobial drug resistance Anna Lönnroth Sjödén Unit Infectious Diseases, Directorate Health DG Research European Commission

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

European Regional Verification Commission for Measles and Rubella Elimination (RVC) TERMS OF REFERENCE. 6 December 2011

Joint Statement on Antimicrobial Resistance

Antibiotics and resistance in the WHO Regional Office for Europe. Dr Nienke van de Sande On behalf of the AMR Working Group

Stratégie et action européennes

AVMA Headquarters Externship Program

GOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY

Antimicrobial resistance

GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr. Anders Tegnell, Ministry of Health and Social Affairs, Sweden

Strengthening Epidemiology Capacity Using a One Health Framework in South Asia

Vice President of Development Denver, CO

Tackling the need for new antibacterial drugs

W O s trategi g c i actio i n o n pl p a l n n on o ant n ib i i b o i t o ic i resis i tanc n e in i n Eu E r u op o e p

HMA-V Action plan on antimicrobial issues Version for publication (27 January 2011)

Good governance and the evaluation of Veterinary Services

Antimicrobial resistance. Summary of OIE Activities

Antimicrobial resistance: the challenges for animal health

funded by Reducing antibiotics in pig farming

Would you like to be added to our mailing list to receive updates on the development of the global action plan?* Y X N

Healthcare Facilities and Healthcare Professionals. Public

THE GOVERNMENT OF FIJI FIJI NATIONAL ANTIMICROBIAL RESISTANCE ACTION PLAN

Combating Antimicrobial Resistance: A Manufacturing Perspective

Transcription:

AIHA Internet Resources Digest Supporting Access to High Quality Online Resources June 2015 Spotlight on: Resources on Rational Antibiotic Use Tntibiotic resistance is a growing problem and the main cause of this problem is misuse of antibiotics. In recent years, a wide range of initiatives and activities, aimed specifically at addressing the challenge of antimicrobial resistance, have been launched by governments, nongovernmental alliances and private entities around the world International Organizations and Projects CDC s Get Smart: Know When Antibiotics Work CDC s Get Smart: Know When Antibiotics Work program works to make sure antibiotics are prescribed only when they are needed and used as they should. The Get Smart program focuses on common illnesses that account for most of the antibiotic prescriptions written for children and adults in doctors offices and other outpatient settings. The Get Smart program offers a number of materials and tools to help you learn about antibiotic resistance and appropriate antibiotic prescribing and use for common infections. Materials for healthcare professionals and patients, proven evidence-based methods to optimize antibiotic therapy, international and national programs and measuring activities, printed material, videos and social media tools, research articles. Permission is not needed to print, copy, or distribute any materials from the Get Smart program. http://www.cdc.gov/getsmart/community/ index.html WHO - Drug resistance

Page 2 Antimicrobial resistance is occurring everywhere in the world, compromising our ability to treat infectious diseases, as well as undermining many other advances in health and medicine. For World Health Day 2011, the World Health Organization (WHO) introduced a 6- point policy package to combat the spread of antimicrobial resistance. As part of its core functions, WHO has called together a Strategic and Technical Advisory Group to review and help shape a global strategy to tackle the growing challenge of antimicrobial resistance, and to advise WHO on the coordination role it should be playing in the fight against antimicrobial resistance. The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them. The WHO Global Strategy for Containment of Antimicrobial Resistance identifies 68 prioritized recommendations, for implementation targeted the following groups: Patients and the general community Prescribers and dispensers Hospitals Antimicrobials use in food-producing animals National governments and health systems Industry and research group International organizations http://www.who.int/drugresistance/en/ Global Antibiotic Resistance Partnership GARP was started in 2009 to create a platform for developing actionable policy proposals on antibiotic resistance in low-income and middle-income countries. National GARP working groups are established in: India, Kenya, South Africa, Vietnam, Mozambique, Nepal, Tanzania and Uganda. GARP is a Center for Disease Dynamics, Economics & Policy (CDDEP) project. On the web-site you can find tools, publications, news, information about projects and events. http://www.cddep.org/projects/globalantibiotic-resistance-partnership Global Health Security Agenda (GHSA) The GHSA was launched in February 2014. Through the Global Health Security agenda, the United States seeks to accelerate progress toward a world safe and secure from infectious disease threats and to promote global health security as an international security priority. One of its identified Global Health Security Risks is Rise of drug resistance. Antimicrobial Resistance Action Package (GHSA Action Package Prevent-1) is under development. http://www.globalhealth.gov/global-health -topics/global-health-security/ ghsagenda.html http://www.cdc.gov/globalhealth/security/ actionpackages/ antimicrobial_resistance.htm

Page 3 European Commission Action plan against the rising threats from Antimicrobial Resistance The European Commission's 2011 five-year action plan contains 12 actions for implementation with EU member countries and identifies 7 areas where measures are most necessary. The Commission has compiled a detailed overview of the 12 Actions covered by the action plan, including the operational objectives, the concrete activities and the deadlines. Joint Conference on Antimicrobial Resistance: State of Play of the 5-year action plan (December 2013). Action Plan Against the rising threats from Antimicrobial Resistance: Road Map (2014). It is also a trustworthy gateway to a wide range of information and data on Antimicrobial Resistance issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), by international organizations; and by pan- European non-governmental organizations in the area of public health. http:// ec.europa.eu/health/ antimicrobial_resistance/policy/ index_en.htm Transatlantic Task Force on Antimicrobial resistance (TATFAR) TATFAR was created in 2009 with the goal of improving cooperation between the U.S. and the EU in three key areas: (1) appropriate therapeutic use of antimicrobial drugs in medical and veterinary communities; (2) prevention of healthcare and community-associated drugresistant infections; (3) strategies for improving the pipeline of new antimicrobial drugs. http://www.cdc.gov/drugresistance/ tatfar/index.html ReAct - Action on Antibiotic Resistance ReAct - Action on Antibiotic Resistance is an independent global network for concerted action on antibiotic resistance. ReAct works across disciplines, bringing stakeholders together in developing ways forward, promoting best practices and innovative solutions, advocating and mobilizing for behavioral change. The resource center section includes a selection of published articles, reports and web tools to facilitate action on antibiotic resistance. ReAct Toolbox is a web-based resource for taking action on antibiotic resistance. The Toolbox is built on what has been done in the past in a variety of settings and is aligned with ongoing and current initiatives from across the globe. Throughout the Toolbox a narrative text guides the user on how to work with the problem, combining practical advice with examples from the field and providing links to external resources that may be useful in your setting. Many of the resources can be adapted and implemented in a variety of contexts http://www.reactgroup.org/

Page 4 Journals and Articles The Journal of Infection in Developing Countries The development of reliable methods for restoring susceptibility after antibiotic resistance arises has proven elusive. A greater understanding of the relationship between antibiotic administration and the evolution of resistance is a key to overcoming this challenge. Here we present a data-driven mathematical approach for developing antibiotic treatment plans that can reverse the evolution of antibiotic resistance determinants. Published: May 6, 2015 Additional 664 results for subject:"antibiotic resistance from this journal http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0122283 The mission of the journal is to provide all infectious disease researchers from developing countries with an international forum for publishing their research findings. The JIDC publishes original research papers, research notes, guidance documents and reviews covering different aspects of human, animal and environmental microbiology and infections in developing countries. JIDC provides pre-review mentoring to help researchers in developing countries produce articles that meet the standards of international journals. This journal provides immediate open access to its content. Search for articles on antimicrobial resistance produced 140 results. http://www.jidc.org/index.php/journal Rational Design of Antibiotic Treatment Plans: A Treatment Strategy for Managing Evolution and Reversing Resistance http://www.plosone.org/search/advanced? u n f o r m a t t e d Q u e r y = s u b j e c t % 3 A % 22Antibiotic%20resistance%22 The International Journal of Antimicrobial Agents The International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents. In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents. Special attention is given to articles providing insight into the problems of antimicrobial resistance both in the hospital and in the community. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published. Selected open access articles. http://www.ijaaonline.com/

Page 5 About the AIHA Internet Resources Digest The Internet Resources Digest previously called the Health Resources Digest is distributed free of charge as a service of the American International Health Alliance s Knowledge Management Program thanks to the generous support of the American people through the US President s Emergency Plan for AIDS Relief (PEPFAR). The Knowledge Management Program is implemented through AIHA s HIV/AIDS Twinning Center Program, which is funded through a cooperative agreement with the US Department of Health and Human Services, Health Resources and Services Administration (HRSA). The Internet Resources Digest is compiled by Irina Ibraghimova, PhD, Library and Information Management Specialist HealthConnect International (www.healthconnect-intl.org). The contents are the responsibility of AIHA and do not necessarily reflect the views of PEPFAR, HRSA, or the United States Government. If you have a suggestion for a Digest topic, or would like to contribute information about Internet resources, please contact ibra[at]zadar.net. Back issues of the Internet Resources Digest for 2011-2015 are archived at http://www.healthconnect-intl.org/ resources.html If this document is to be redistributed or posted on another Web site, we request that it be posted in full without alteration, and credit is given to the AIHA as the source of the document.